“Asthma alone is a $50 billion problem in the United States. We look forward to accelerating our commercial efforts to improve asthma control and produce sizable economic savings,” said David Van Sickle, CEO and co-founder of Asthmapolis. Mark Gehring, Asthmapolis president and co-founder, added, “To date we’ve helped our users achieve an extra 20,000 asthma-free days. Each day they feel better is also a day they don’t end up in the emergency department, which means reduced costs for our payer and health system customers.”